Foresite Capital Management Iv, LLC Portfolio Holdings

Foresite Capital Management Iv, LLC

  • $109 Million
  • Q4 2024

Foresite Capital Management Iv, LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $109 Million distributed in 4 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Pharvaris N.V. with a value of $84.3M, Kura Oncology, Inc. with a value of $15M, Lyell Immunopharma, Inc. with a value of $5.33M, and Relay Therapeutics, Inc. with a value of $4.12M.

Examining the 13F form we can see an decrease of $44.2M in the current position value, from $153M to 109M.

Foresite Capital Management Iv, LLC is based out at Larkspur, CA

Below you can find more details about Foresite Capital Management Iv, LLC portfolio as well as his latest detailed transactions.

Portfolio value $109 Million
Healthcare: $109 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$173M
$5.33 Million 4.9% of portfolio
8,325,000
Q4 2023 Reduced 5.23%

Summary

  • Portfolio
  • No. of Stocks 4
  • Current Value $109 Million
  • Prior Value $153 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Foresite Capital Management Iv, LLC Portfolio

Follow Foresite Capital Management Iv, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iv, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Management Iv, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email